Zhenglin Jiang

Prof. Zhenglin Jiang

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2011 in Journal of Neurotrauma
Verified
Journal Article
Closed access
Guohua WangGuohua Wang
Guohua Wang
ZJZhenglin Jiang
Zhenglin Jiang
YLYong-Cai Li
Yong-Cai Li
XLXia Li
Xia Li
HSHong Shi
Hong Shi
JCJun Chen
Jun Chen
Traumatic brain injury (TBI) is one of the leading causes of neurological disability in young adults. Edaravone, a novel synthetic small-molecule free-radical scavenger, has been shown to have a neuroprotective effect in both animal models of cerebral ischemia and stroke patients; however, the underlying mechanism is poorly understood. In this report, we investigated the potential mechanisms of edaravone treatment in a rat model of TBI. TBI was induced in the right cerebral cortex of male adult rats using Feeney's weight-drop method. Edaravone (0.75, 1.5, or 3 mg/kg) or vehicle (normal saline) was intravenously administered at 2 and 12 h after TBI. Edaravone treatment significantly decreased hippocampal CA3 neuron loss, reduced oxidative stress, and decreased neuronal programmed cell death compared to vehicle treatment. The protective effects of edaravone treatment were also related to the pathology of TBI on non-neuronal cells, as edaravone decreased astrocyte and glial activation. Lastly, edaravone treatment significantly reduced the presence of inflammatory cytokines, cerebral edema, blood–brain barrier (BBB) permeability, and, importantly, neurological deficits following TBI. Our results suggest that edaravone exerts a neuroprotective effect in the rat model of TBI. The likely mechanism is via inhibiting oxidative stress, leading to a decreased inflammatory response and glial activation, and thereby reducing neuronal death and improving neurological function.

20 April 2019 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
CGChunyi Gao
Chunyi Gao
XYXiaoyu Yuan
Xiaoyu Yuan
ZJZhenglin Jiang
Zhenglin Jiang
DGDeqiang Gan
Deqiang Gan
LDLingzhi Ding
Lingzhi Ding
Guohua WangGuohua Wang
Guohua Wang

1 September 2010 in Journal of Neurotrauma
Verified
Journal Article
Closed access
Guohua WangGuohua Wang
Guohua Wang
XZXiang-Gen Zhang
Xiang-Gen Zhang
ZJZhenglin Jiang
Zhenglin Jiang
XLXia Li
Xia Li
LPLiang-Liang Peng
Liang-Liang Peng
YWYong Wang
Yong Wang
This study was designed to evaluate the potential benefits of hyperbaric oxygen (HBO) in the treatment of traumatic brain injury (TBI). The right cerebral cortex of rats was injured by the impact of a 20-g object dropped from a predetermined height. The rats received HBO treatment at 3 ATA for 60 min after TBI. Neurological behavior score, brain water content, neuronal loss in the hippocampus, and cell apoptosis in brain tissue surrounding the primary injury site were examined to determine brain damage severity. Three and six hours after TBI, HBO-treated rats displayed a significant reduction in brain damage. However, by 12 h after TBI, the efficacy of HBO treatment was considerably attenuated. Furthermore, at 24, 48, and 72 h after TBI, the HBO treatment did not show any notable effects. In contrast, multiple HBO treatments (three or five times in all), even when started 48 h after TBI, remarkably reduced neurology deficit scores and the loss of neuronal numbers in the hippocampus. Although multiple treatments started at 48 h significantly improved neurological behaviors and reduced brain injury, the overall beneficial effects were substantially weaker than those seen after a single treatment at 6 h. These results suggest that: (1) HBO treatment could alleviate brain damage after TBI; (2) a single treatment with HBO has a time limitation of 12 h post-TBI; and (3) multiple HBO treatments have the possibility to extend the post-TBI delivery time window. Therefore, our results clearly suggest the validity of HBO therapy for the treatment of TBI.

1 September 2014 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
BHBao-Ying Hu
Bao-Ying Hu
XLXian-Jin Liu
Xian-Jin Liu
RQRen Qiang
Ren Qiang
ZJZhenglin Jiang
Zhenglin Jiang
LXLi-Hua Xu
Li-Hua Xu
BPBin Peng
Bin Peng

1 August 2015 in Neuropharmacology
Verified
Journal Article
Closed access
PZPei-Pei Zhai
Pei-Pei Zhai
LXLi-Hua Xu
Li-Hua Xu
JYJuan-Juan Yang
Juan-Juan Yang
ZJZhenglin Jiang
Zhenglin Jiang
GZGuang-Wei Zhao
Guang-Wei Zhao
XLXia Li
Xia Li

22 February 2010 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
Guohua WangGuohua Wang
Guohua Wang
ZJZhenglin Jiang
Zhenglin Jiang
ZCZhao‐Qin Chen
Zhao‐Qin Chen
XLXia Li
Xia Li
LPLiang‐Liang Peng
Liang‐Liang Peng